Fresenius Medical Care AG (VIE:FME)
Austria · Delayed Price · Currency is EUR 39.07
-0.40 (-1.01%)
At close: Mar 4, 2026
Fresenius Medical Care AG Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | - | - | - | 894.33 | 1,219 |
Depreciation & Amortization | 1,500 | 1,742 | 1,752 | 1,838 | 1,624 |
Other Adjustments | 368.66 | 216.42 | 299.54 | 180.39 | 358.07 |
Change in Receivables | -76.45 | -197.92 | -125.59 | -76.66 | -100.55 |
Changes in Inventories | -248.66 | 107.9 | -13.14 | -204.31 | -48.53 |
Changes in Accounts Payable | 27.21 | -46.2 | -10.91 | -8.73 | 19.7 |
Changes in Accrued Expenses | -14.77 | 201.79 | 119.38 | -348.06 | -383.65 |
Changes in Income Taxes Payable | 236.61 | 482.27 | 472.08 | 325.68 | 313.71 |
Changes in Other Operating Activities | 214.28 | -103.53 | 119.45 | 184.01 | 101.55 |
Operating Cash Flow | 2,681 | 2,386 | 2,629 | 2,167 | 2,489 |
Operating Cash Flow Growth | 12.36% | -9.23% | 21.29% | -12.94% | -41.19% |
Capital Expenditures | -915.37 | -699.36 | -684.6 | -723.99 | -854.36 |
Sale of Property, Plant & Equipment | 16.7 | 14.1 | 16.14 | 36.21 | 24.42 |
Purchases of Investments | -87.52 | -81.5 | -102.36 | -105.64 | -129.08 |
Proceeds from Sale of Investments | 83.5 | 75.13 | 89.6 | 57.67 | 144.52 |
Payments for Business Acquisitions | -21.97 | -23.07 | -35.2 | -59.13 | -434.17 |
Proceeds from Business Divestments | 202.14 | 629.75 | 172.2 | 60.16 | 52.44 |
Investing Cash Flow | -722.53 | -84.94 | -544.23 | -734.73 | -1,196 |
Short-Term Debt Issued | 156.46 | 84.81 | 65.34 | 717.09 | 1,804 |
Short-Term Debt Repaid | -140.81 | -540.5 | -244.98 | -1,302 | -627.25 |
Net Short-Term Debt Issued (Repaid) | 15.65 | -455.69 | -179.64 | -585.16 | 1,177 |
Long-Term Debt Issued | 1,623 | 61.51 | 417.88 | 986.92 | 1,244 |
Long-Term Debt Repaid | -839.59 | -834.46 | -700.66 | -744.62 | -2,083 |
Net Long-Term Debt Issued (Repaid) | 782.97 | -772.95 | -282.79 | 242.3 | -838.91 |
Issuance of Common Stock | - | - | - | 20.15 | 6.51 |
Repurchase of Common Stock | -585.29 | - | - | - | - |
Net Common Stock Issued (Repurchased) | -585.29 | - | - | 20.15 | 6.51 |
Common Dividends Paid | -422.52 | -349.16 | -328.62 | -395.56 | -392.46 |
Other Financing Activities | -1,194 | -991.5 | -1,067 | -899.1 | -976.49 |
Financing Cash Flow | -1,403 | -2,569 | -1,859 | -1,617 | -1,024 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | -141.48 | 26.2 | -72.61 | -23.16 | 131.23 |
Net Cash Flow | 413.79 | -241.9 | 153.44 | -207.87 | 400.12 |
Free Cash Flow | 1,766 | 1,687 | 1,944 | 1,443 | 1,635 |
Free Cash Flow Growth | 4.67% | -13.24% | 34.70% | -11.73% | -48.60% |
FCF Margin | 9.00% | 8.72% | 9.99% | 7.44% | 9.28% |
Free Cash Flow Per Share | 3.03 | 2.87 | 3.31 | 2.46 | 2.79 |
Levered Free Cash Flow | 2,577 | 994.41 | 1,791 | 1,394 | 2,079 |
Unlevered Free Cash Flow | 2,096 | 2,567 | 2,639 | 2,014 | 2,137 |
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.